8-K 1 miracor_8k-111803.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 18, 2003 MIRACOR DIAGNOSTICS, INC. (Exact name of registrant as specified in its charter) Utah 0-12365 58-1475517 -------------------------------------------------------------------------------- (State or other (Commission (IRS Employer jurisdiction of File Number) Identification No.) formation 9191 Towne Centre Drive, Suite 400, San Diego, California 92122 -------------------------------------------------------------------------------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (858) 455-7127 9191 Towne Centre Drive, Suite 400, San Diego, California 92122 -------------------------------------------------------------------------------- (Former name or former address, if changed since last report) FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Item 1. Changes in Control of Registrant -------------------------------- Not Applicable Item 2. Acquisition or Disposition of Assets ------------------------------------ Not Applicable Item 3. Bankruptcy or Receivership -------------------------- Not Applicable Item 4. Changes in Registrant's Certifying Accountant --------------------------------------------- Not Applicable Item 5. Other Events ------------ Not Applicable Item 6. Resignation of Registrant's Directors ------------------------------------- Not Applicable Item 7. Financial Statements, Pro Forma Financial Information and Exhibits ------------------------------------------------------------------ Exhibit - Press Release Item 8. Change of Fiscal Year --------------------- Not Applicable Item 9. Sales of Equity Securities Pursuant to Regulation S ------- --------------------------------------------------- Not Applicable 2 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly authorized and caused the undersigned to sign this Report on the Registrant's behalf. MIRACOR DIAGNOSTICS, INC. By: /s/ Ross S. Seibert ---------------------------------------- Ross S. Seibert, Chief Financial Officer Dated: November 18, 2003 3 MIRACOR DIAGNOSTICS REPORTS 3RD QUARTER RESULTS SAN DIEGO--November 14, 2003--Miracor Diagnostics, Inc. (OTCBB: MRDG) reported net revenue of $5,155,007 for the three months ended September 30, 2003, a 72% increase compared to net revenue of $2,998,829 for the same period in 2002. Net loss was $343,136 ($0.02 per share) compared to net income of $129,917 ($0.01 per share) in 2002. For the nine months ended September 30, 2003, net revenue was $14,356,796 and net loss was $1,138,334 ($0.07 per share). This compares to net revenue of $8,662,865 and net income of $432,751 ($0.03 per share) for the nine months ended September 30, 2002. Miracor Diagnostics Inc. and Subsidiaries Consolidated Statements of Operations (unaudited)

DVI Inc. and its affiliates, (collectively "DVI"), which include the lenders on several of Miracor's equipment leases and its line of credit, filed for bankruptcy protection in September 2003. Miracor is negotiating with the trustees of DVI and other lenders in order to minimize the impact of the filing on Miracor's operations. ABOUT THE COMPANY Miracor Diagnostics, Inc. is focused on the acquisition, development and operation of diagnostic imaging centers. The company operates the following 14 diagnostic imaging centers:

For more information, visit www.miracor.net. THE FORWARD-LOOKING STATEMENTS CONTAINED IN THIS RELEASE ARE BASED UPON VARIOUS ASSUMPTIONS, AND CERTAIN RISKS AND UNCERTAINTIES COULD CAUSE ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE STATED. FACTORS THAT COULD CAUSE SUCH DIFFERENCES INCLUDE THOSE MATTERS DISCLOSED IN THE COMPANY'S FILINGS WITH THE SECURITIES EXCHANGE COMMISSION (SEC). MIRACOR DIAGNOSTICS INC. ASSUMES NO OBLIGATION TO UPDATE ITS FORWARD-LOOKING STATEMENTS. CONTACT: MIRACOR DIAGNOSTICS, INC. (858) 455-7127 M. LEE HULSEBUS, CHAIRMAN AND CEO, EXT. 11 ROSS SEIBERT, CFO, EXT. 13

MIRACOR DIAGNOSTICS INC 8-K